Back

Cost-effectiveness of implantable cardioverter defibrillator for the primary prevention of sudden death

29 June 2021 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Atrial Fibrillation and Device Therapy Implantable Cardioverter-Defibrillator (ICD) HFA Premium Access Heart Failure 2021

About the speaker

Photo
Doctor Eduard Rodenas Alesina

University Hospital Vall d'Hebron, Barcelona (Spain)

8 More presentations in this session

Presentation thumbnail
Battery-free, miniaturized multisite pacemakers for wireless in vivo electrical and optogenetic stimulation in small animal models
Mr J. Ausra (Tucson, US)
Abstract Slides Video
Presentation thumbnail
Cardiac resynchronisation therapy with or without defibrillator in patients with heart failure - An analysis from the Swedish Heart Failure Registry
Doctor B. Schrage (Hamburg, DE)
Abstract Slides Video
Presentation thumbnail
Impact of gender on left atrial structure and function in patients with recurrent atrial fibrillation
Doctor E. Kokhan (Moscow, RU)
Abstract Slides Video
Presentation thumbnail
Presence of atrial fibrillation prolongs hospital stay in heart failure patients hospitalized with covid-19
Doctor B. MURAT (Eskisehir, TR)
Abstract Slides Video
Presentation thumbnail
Prevalence of obesity and its association with cardiometablic risk factors, heart failure phenotype and mortality among patients hospitalized for heart failure in Egypt
Doctor M. Hassanin (Alexandria, EG)
Abstract Slides Video

Access the full session

Session thumbnail
Atrial Fibrillation and Device Therapy

The Event

Event poster

Heart Failure 2021

29 June - 1 July 2021
You may be interested in
thumbnail
Congress Presentation
Implantable cardioverter-defibrillator
thumbnail
Congress Presentation
When to consider device therapy in HFrEF - discussion
thumbnail
Congress Session
Debate on primary prevention in ICD therapy

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources